The COVID-19 and Cancer Consortium (CCC19) Registry

Study Title

The COVID-19 and Cancer Consortium (CCC19) Registry

Purpose

To collect granular information on cancer patients infected with COVID-19.

Eligibility

Suspected or lab-confirmed COVID-19          

               Current or past medical history of invasive malignancy

Study Process

Contact Principal Investigator for Information

Trial Details

Investigator:

IRB:

Willis-Knighton

IRB Number:

20.0004

Trial Type:

NA

Sponsor:

Vanderbilt University Medical Center

Contact Information:

Hematology Oncology Associates